首页 | 本学科首页   官方微博 | 高级检索  
     

NP与MVP方案治疗非小细胞肺癌的临床观察
引用本文:王志海,纪明. NP与MVP方案治疗非小细胞肺癌的临床观察[J]. 现代医药卫生, 2002, 18(4): 265-266
作者姓名:王志海  纪明
作者单位:青岛医学院第二附属医院,266042
摘    要:
目的:观察诺维本(NVB)+顺铂(DDP)(NP方案)与丝裂霉素(MMC)、西艾克(VDS)加顺铂(MVP方案)治疗晚期非小细胞肺癌(NSCLC)的临床疗效和不良反应。方法:采用NP与MVP两方案分别治疗晚期NSCLC 32例。结果:NP组总有效为43.8%,中位生存期7.7个月,MVP组总有效34.4%,中位生存期9.6个月,NP方案优于MVP方案,但差异无显著性(P>0.05),两组剂量限制毒性均为骨髓抑制。结论:NP与INP方案是治疗晚期NSCLC的有效方案,经积极处理不良反应可以耐受。NP方案可作为首选方案。

关 键 词:非小细胞肺癌 临床观察 NP方案 MVP方案 联合化疗
文章编号:1009-5519(2002)04-0265-02

Clinical observation of NP and MVP combined chemotherapy for treating advanced non-small cell lung carcinoma.
Wang Zhihai,Ji Ming. Clinical observation of NP and MVP combined chemotherapy for treating advanced non-small cell lung carcinoma.[J]. JOURNAL OF MODERN MEDICINE & HEALTH, 2002, 18(4): 265-266
Authors:Wang Zhihai  Ji Ming
Affiliation:Wang Zhihai,Ji Ming.The Second Affiliated Hospital of Qingdao Medical college,Shandong 261011
Abstract:
Objective:To observe the therapeutic effect and toxic side-effects of the combined chemotherapy with navelbine and cisplatin(NP regimen) and with micomycin plus vindesine and cisplatin(MVP regimen) in the treatment of advanced non-small cell lung carcinoma.Methods:Thirty-two patients received NP combied chemotherapy and thirty-two patients reveived MVP combied chemotherapy.Results:The overall response rate was 43.8% in the NP group and 34.4% in the MVP group.The median survival period was 7.7 months and 9.6 months respectively.NP regimen is better than MVP regimen in efficacy,but not dramatically different.Conclusion:This study shows that NP and MVP are active and tolerable regimens for trealment of advanced non-small cell lung carcinoma.
Keywords:NP regimen MVP regimen Advanced non-small cell lung carcinoma Combined chemotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号